FRI0291 Decrease in Anti-Osteoporotic Drugs Prescriptions: Is there an Immediate Consequence on Hip Fracture Incidence?

BackgroundThe incidence of hip fractures decreased in France in both genders, especially in the elderly, from 2002 to 2008, in parallel with availability of bone densitometry and effective anti-osteoporotic treatments. However prescriptions of those treatments are decreasing, since 2008, and recent studies show declining of osteoporosis management after fragility fractures.ObjectivesThe aim of this study was to assess the incidence of hip fractures in men and women aged 60 years and over, from 2002 to 2013 in France, and to assess the potential effect of these treatment changes.MethodsData were drawn from the French Hospital National Database which includes all hospitalizations. Hospital data for hip fractures between 2002 and 2013 were numbered and the incidence rates per 1,000,000 adjusted on age (60-74; 74-84, and ≥85 years), and gender was calculated using the data of the French population.ResultsWe did not observe any change in hip fracture incidence before and after 2008; The number of hip fractures increased in women (+5%; from 49,287 in 2002 to 50,215) and in men (+22%, from 12,716 to 15,482). Between 2002 and 2013, the French population increased by 21 and 29% in women and men. Thus, incidence of hip fractures over 60 years decreased by -14% in women (6,929 and 5,987 per million in 2002 and 2013, respectively) and a slight decrease of -1%was observed in men (2,344 and 2,316). An age-specific incidence decrease was also confirmed, with a decrease of -29% and -24% (p